We are live on ! Find out more
TCM

Tetrem Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 16.55%
This Fund
S&P 500
This Quarter Est. Return
+5.91%
1 Year Est. Return
+16.55%
3 Year Est. Return
+11.29%
5 Year Est. Return
10 Year Est. Return
AUM
$2.66B
AUM Growth
+$83.5M
Cap. Flow
-$44M
Cap. Flow %
-1.65%
Top 10 Hldgs %
38.46%
Holding
65
New
1
Increased
26
Reduced
31
Closed
4

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$33.5M
2
CCI icon
Crown Castle
CCI
+$26.6M
3
ETN icon
Eaton
ETN
+$22.9M
4
SU icon
Suncor Energy
SU
+$16.4M
5
RY icon
Royal Bank of Canada
RY
+$15.2M

Sector Composition

Rank Sector Weight
1 Financials 32.15%
2 Energy 13.94%
3 Industrials 11.3%
4 Healthcare 11.04%
5 Communication Services 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
26
Procter & Gamble
PG
$338B
$45.2M 1.7%
503,689
-15,239
-3% -$1.32M
AFL icon
27
Aflac
AFL
$64.5B
$44.8M 1.68%
1,245,852
-38,786
-3% -$1.41M
MA icon
28
Mastercard
MA
$500B
$44.6M 1.68%
438,502
+34,772
+9% +$3.33M
WFC icon
29
Wells Fargo
WFC
$266B
$44M 1.65%
994,339
+38,560
+4% +$1.85M
CCI icon
30
Crown Castle
CCI
$33.5B
$42.4M 1.59%
449,658
+276,105
+159% +$26.6M
MDT icon
31
Medtronic
MDT
$111B
$40.2M 1.51%
465,792
-102,825
-18% -$8.96M
ENB icon
32
Enbridge
ENB
$118B
$38.3M 1.44%
866,600
-295,705
-25% -$12.4M
NLSN
33
DELISTED
Nielsen Holdings plc
NLSN
$38M 1.43%
708,598
-21,384
-3% -$1.14M
CMCSA icon
34
Comcast
CMCSA
$87.2B
$36.6M 1.37%
1,102,680
-178,826
-14% -$5.95M
WCN
35
Waste Connections
WCN
$42.3B
$36.6M 1.37%
735,134
-32,259
-4% -$1.63M
QCOM icon
36
Qualcomm
QCOM
$159B
$36M 1.35%
525,766
+224,155
+74% +$13.6M
FNF icon
37
Fidelity National Financial
FNF
$13.9B
$35.4M 1.33%
1,380,462
+82,301
+6% +$2.13M
HAL icon
38
Halliburton
HAL
$26.6B
$35.1M 1.32%
783,057
-167,252
-18% -$7.3M
M icon
39
Macy's
M
$6.83B
$34.8M 1.31%
938,102
-28,761
-3% -$1.04M
HOG icon
40
Harley-Davidson
HOG
$2.66B
$33.5M 1.26%
637,542
-108,000
-14% -$5.58M
GILD icon
41
Gilead Sciences
GILD
$163B
$32.7M 1.23%
+412,773
New +$33.5M
TJX icon
42
TJX Companies
TJX
$174B
$32.6M 1.22%
871,660
+108,890
+14% +$4.26M
UNH icon
43
UnitedHealth
UNH
$377B
$31.8M 1.19%
227,065
+38,296
+20% +$5.36M
TRP icon
44
TC Energy
TRP
$68.6B
$28.2M 1.06%
591,134
+269,824
+84% +$12.6M
PDS
45
Precision Drilling
PDS
$996M
$28M 1.05%
335,023
-5,023
-1% -$441K
MON
46
DELISTED
Monsanto Co
MON
$24.5M 0.92%
239,776
-7,104
-3% -$745K
HPE icon
47
Hewlett Packard
HPE
$66.5B
$24.1M 0.9%
1,819,023
-1,053,119
-37% -$13M
ETN icon
48
Eaton
ETN
$170B
$23.6M 0.89%
359,560
+353,607
+5,940% +$22.9M
STN icon
49
Stantec
STN
$8.17B
$11.1M 0.42%
470,975
-21,917
-4% -$526K
VZ icon
50
Verizon
VZ
$198B
$3.1M 0.12%
59,563
-23,138
-28% -$1.24M

Similar funds

Tetrem Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Tetrem Capital Management held 65 positions worth $2.66B, up 3.2% from $2.58B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tetrem Capital Management's Q3 2016 filing shows 1 new, 26 increased, 31 reduced and 4 closed positions. Its largest new stake was Gilead Sciences: 412,773 shares worth $32.7M. The largest sale was Teva Pharmaceuticals, an estimated $35.4M.

By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 32% a quarter earlier, followed by Energy and Industrials.

  • Tetrem Capital Management's largest Q3 2016 buy was Gilead Sciences: 412,773 shares worth $32.7M.
  • Tetrem Capital Management added most to Crown Castle in Q3 2016, an estimated $26.6M increase.
  • Tetrem Capital Management's biggest Q3 2016 reduction was Manulife Financial, cutting an estimated $23.5M.
  • Tetrem Capital Management fully exited Teva Pharmaceuticals in Q3 2016, selling an estimated $35.4M.
  • Tetrem Capital Management's ten largest holdings make up 38% of its $2.66B portfolio in Q3 2016.
  • Tetrem Capital Management opened 1 new position and closed 4 in Q3 2016.
  • Tetrem Capital Management's portfolio value rose 3.2% quarter-over-quarter to $2.66B.

Based on Tetrem Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.